c. diff tox-a/b quik chek (TechLab Inc)
90
Structured Review
TechLab Inc
c. diff tox-a/b quik chek
C. Diff Tox A/B Quik Chek, supplied by TechLab Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/diff+quik/c++diff+quik+chek+complete/pmc03416433-200-7-12
Average 90 stars, based on 1 article reviews
C. Diff Tox A/B Quik Chek, supplied by TechLab Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/diff+quik/c++diff+quik+chek+complete/pmc03416433-200-7-12
Average 90 stars, based on 1 article reviews
c. diff tox-a/b quik chek - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
Enzyme-linked Immunosorbent Assay:Article Title: Evaluation of three commercial rapid immunoassays for the diagnosis of Clostridioides difficile infection. Article Snippet: TABLE 1 Detection of GDH and toxins A/B with three rapid immunoassays compared to tcdA detection with the Alethia C. difficile (Meridian) Consecutive samples, n = 57 Frozen samples (positive with Alethia), n = 47 Alethia C. difficile (Meridian) 14 47 Article Title: Antibiotic De-Escalation in the Intensive Care Unit: Rationale and Potential Strategies Article Snippet: Enzyme immunoassay , Article Title: Clinical and Microbiological Characteristics of Hospitalized Adults Aged ≤ 45 Years With Clostridioides (Formerly Clostridium ) difficile Infection: A Prospective Observational Cohort Study From Hungary Article Snippet: Diagnosis was made by a clinically compatible case presentation (diarrhea, ileus, toxic megacolon or CDI associated sepsis) plus confirmation of a toxin‐producing C. difficile strain from an unformed stool sample, using enzyme immuno‐assay targeting glutamate dehydrogenase and Article Title: Evaluation of three commercial rapid immunoassays for the diagnosis of Clostridioides difficile infection. Article Snippet: In this study, we evaluated the Article Title: Impact of the COVID-19 Pandemic on Clostridioides difficile Infection Rates in a Tertiary Hospital: A Retrospective Comparative Study Article Snippet: Initial screening used the Article Title: Risk factors for the development of Clostridioides difficile infection in patients colonized with toxigenic Clostridioides difficile Article Snippet: Testing for CDI was performed on unformed stool samples using a two-step algorithm; glutamate dehydrogenase (GDH) testing followed by confirmatory Article Title: Shigella flexneri Outbreak at a Rehabilitation Center: First Report from Saudi Arabia. Article Snippet: Additionally, the stool tested negative for Clostridium difficile toxin using Article Title: Evaluation of a Fluorescence Immunoassay for Detection of Clostridioides difficile Glutamate Dehydrogenase and Toxin Antigens. Article Snippet: Samples were concurrently tested using the Sofia 2 C. difficile FIA (Sofia 2, QuidelOrtho) and Diff-Quik:Article Title: Evaluation of three commercial rapid immunoassays for the diagnosis of Clostridioides difficile infection. Article Snippet: TABLE 1 Detection of GDH and toxins A/B with three rapid immunoassays compared to tcdA detection with the Alethia C. difficile (Meridian) Consecutive samples, n = 57 Frozen samples (positive with Alethia), n = 47 Alethia C. difficile (Meridian) 14 47 Article Title: Antibiotic De-Escalation in the Intensive Care Unit: Rationale and Potential Strategies Article Snippet: Enzyme immunoassay , Article Title: Clinical and Microbiological Characteristics of Hospitalized Adults Aged ≤ 45 Years With Clostridioides (Formerly Clostridium ) difficile Infection: A Prospective Observational Cohort Study From Hungary Article Snippet: Diagnosis was made by a clinically compatible case presentation (diarrhea, ileus, toxic megacolon or CDI associated sepsis) plus confirmation of a toxin‐producing C. difficile strain from an unformed stool sample, using enzyme immuno‐assay targeting glutamate dehydrogenase and Article Title: Evaluation of three commercial rapid immunoassays for the diagnosis of Clostridioides difficile infection. Article Snippet: In this study, we evaluated the Article Title: Impact of the COVID-19 Pandemic on Clostridioides difficile Infection Rates in a Tertiary Hospital: A Retrospective Comparative Study Article Snippet: Initial screening used the Article Title: Risk factors for the development of Clostridioides difficile infection in patients colonized with toxigenic Clostridioides difficile Article Snippet: Testing for CDI was performed on unformed stool samples using a two-step algorithm; glutamate dehydrogenase (GDH) testing followed by confirmatory Article Title: Shigella flexneri Outbreak at a Rehabilitation Center: First Report from Saudi Arabia. Article Snippet: Additionally, the stool tested negative for Clostridium difficile toxin using Article Title: Evaluation of a Fluorescence Immunoassay for Detection of Clostridioides difficile Glutamate Dehydrogenase and Toxin Antigens. Article Snippet: Samples were concurrently tested using the Sofia 2 C. difficile FIA (Sofia 2, QuidelOrtho) and Biomarker Discovery:Article Title: Evaluation of three commercial rapid immunoassays for the diagnosis of Clostridioides difficile infection. Article Snippet: TABLE 1 Detection of GDH and toxins A/B with three rapid immunoassays compared to tcdA detection with the Alethia C. difficile (Meridian) Consecutive samples, n = 57 Frozen samples (positive with Alethia), n = 47 Alethia C. difficile (Meridian) 14 47 Article Title: Antibiotic De-Escalation in the Intensive Care Unit: Rationale and Potential Strategies Article Snippet: Enzyme immunoassay , Article Title: Clinical and Microbiological Characteristics of Hospitalized Adults Aged ≤ 45 Years With Clostridioides (Formerly Clostridium ) difficile Infection: A Prospective Observational Cohort Study From Hungary Article Snippet: Diagnosis was made by a clinically compatible case presentation (diarrhea, ileus, toxic megacolon or CDI associated sepsis) plus confirmation of a toxin‐producing C. difficile strain from an unformed stool sample, using enzyme immuno‐assay targeting glutamate dehydrogenase and Article Title: Evaluation of three commercial rapid immunoassays for the diagnosis of Clostridioides difficile infection. Article Snippet: In this study, we evaluated the Article Title: Impact of the COVID-19 Pandemic on Clostridioides difficile Infection Rates in a Tertiary Hospital: A Retrospective Comparative Study Article Snippet: Initial screening used the Article Title: Risk factors for the development of Clostridioides difficile infection in patients colonized with toxigenic Clostridioides difficile Article Snippet: Testing for CDI was performed on unformed stool samples using a two-step algorithm; glutamate dehydrogenase (GDH) testing followed by confirmatory Article Title: Shigella flexneri Outbreak at a Rehabilitation Center: First Report from Saudi Arabia. Article Snippet: Additionally, the stool tested negative for Clostridium difficile toxin using Article Title: Evaluation of a Fluorescence Immunoassay for Detection of Clostridioides difficile Glutamate Dehydrogenase and Toxin Antigens. Article Snippet: Samples were concurrently tested using the Sofia 2 C. difficile FIA (Sofia 2, QuidelOrtho) and Immuno Assay:Article Title: Evaluation of three commercial rapid immunoassays for the diagnosis of Clostridioides difficile infection. Article Snippet: TABLE 1 Detection of GDH and toxins A/B with three rapid immunoassays compared to tcdA detection with the Alethia C. difficile (Meridian) Consecutive samples, n = 57 Frozen samples (positive with Alethia), n = 47 Alethia C. difficile (Meridian) 14 47 Article Title: Antibiotic De-Escalation in the Intensive Care Unit: Rationale and Potential Strategies Article Snippet: Enzyme immunoassay , Article Title: Clinical and Microbiological Characteristics of Hospitalized Adults Aged ≤ 45 Years With Clostridioides (Formerly Clostridium ) difficile Infection: A Prospective Observational Cohort Study From Hungary Article Snippet: Diagnosis was made by a clinically compatible case presentation (diarrhea, ileus, toxic megacolon or CDI associated sepsis) plus confirmation of a toxin‐producing C. difficile strain from an unformed stool sample, using enzyme immuno‐assay targeting glutamate dehydrogenase and Article Title: Evaluation of three commercial rapid immunoassays for the diagnosis of Clostridioides difficile infection. Article Snippet: In this study, we evaluated the Article Title: Impact of the COVID-19 Pandemic on Clostridioides difficile Infection Rates in a Tertiary Hospital: A Retrospective Comparative Study Article Snippet: Initial screening used the Article Title: Risk factors for the development of Clostridioides difficile infection in patients colonized with toxigenic Clostridioides difficile Article Snippet: Testing for CDI was performed on unformed stool samples using a two-step algorithm; glutamate dehydrogenase (GDH) testing followed by confirmatory Article Title: Shigella flexneri Outbreak at a Rehabilitation Center: First Report from Saudi Arabia. Article Snippet: Additionally, the stool tested negative for Clostridium difficile toxin using Article Title: Evaluation of a Fluorescence Immunoassay for Detection of Clostridioides difficile Glutamate Dehydrogenase and Toxin Antigens. Article Snippet: Samples were concurrently tested using the Sofia 2 C. difficile FIA (Sofia 2, QuidelOrtho) and Surround Optical-fiber Immunoassay:Article Title: Evaluation of three commercial rapid immunoassays for the diagnosis of Clostridioides difficile infection. Article Snippet: TABLE 1 Detection of GDH and toxins A/B with three rapid immunoassays compared to tcdA detection with the Alethia C. difficile (Meridian) Consecutive samples, n = 57 Frozen samples (positive with Alethia), n = 47 Alethia C. difficile (Meridian) 14 47 Article Title: Antibiotic De-Escalation in the Intensive Care Unit: Rationale and Potential Strategies Article Snippet: Enzyme immunoassay , Article Title: Clinical and Microbiological Characteristics of Hospitalized Adults Aged ≤ 45 Years With Clostridioides (Formerly Clostridium ) difficile Infection: A Prospective Observational Cohort Study From Hungary Article Snippet: Diagnosis was made by a clinically compatible case presentation (diarrhea, ileus, toxic megacolon or CDI associated sepsis) plus confirmation of a toxin‐producing C. difficile strain from an unformed stool sample, using enzyme immuno‐assay targeting glutamate dehydrogenase and Article Title: Evaluation of three commercial rapid immunoassays for the diagnosis of Clostridioides difficile infection. Article Snippet: In this study, we evaluated the Article Title: Impact of the COVID-19 Pandemic on Clostridioides difficile Infection Rates in a Tertiary Hospital: A Retrospective Comparative Study Article Snippet: Initial screening used the Article Title: Risk factors for the development of Clostridioides difficile infection in patients colonized with toxigenic Clostridioides difficile Article Snippet: Testing for CDI was performed on unformed stool samples using a two-step algorithm; glutamate dehydrogenase (GDH) testing followed by confirmatory Article Title: Shigella flexneri Outbreak at a Rehabilitation Center: First Report from Saudi Arabia. Article Snippet: Additionally, the stool tested negative for Clostridium difficile toxin using Article Title: Evaluation of a Fluorescence Immunoassay for Detection of Clostridioides difficile Glutamate Dehydrogenase and Toxin Antigens. Article Snippet: Samples were concurrently tested using the Sofia 2 C. difficile FIA (Sofia 2, QuidelOrtho) and |